Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18

Heterologous immunization is garnering attention as a promising strategy to improve vaccine efficacy. Vaccines based on recombinant baculovirus (rBV) and virus-like particle (VLP) are safe for use, but heterologous immunization studies incorporating these two vaccine platforms remain unreported to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Keon-Woong, Chu, Ki-Back, Kang, Hae-Ji, Kim, Min-Ju, Eom, Gi-Deok, Mao, Jie, Lee, Su-Hwa, Ahmed, Md Atique, Quan, Fu-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609909/
https://www.ncbi.nlm.nih.gov/pubmed/36298453
http://dx.doi.org/10.3390/vaccines10101588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609909/
https://www.ncbi.nlm.nih.gov/pubmed/36298453
http://dx.doi.org/10.3390/vaccines10101588

Ejemplares similares